Effect of Moxifloxacin on Production of Proinflammatory Cytokines from Human Peripheral Blood Mononuclear Cells

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 12, 2003, Pages 3704-3707

  Choi, Jung Hyun ^a   Song, Min Jin ^a   Kim, Seung Han ^a   Choi, Su Mi ^a   Lee, Dong Gun ^a   Yoo, Jin Hong ^a   Shin, Wan Shik ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CEFTRIAXONE; CYTOKINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LEVOFLOXACIN; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MOXIFLOXACIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL POPULATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANTI-INFECTIVE AGENTS; ANTIGENS, CD14; AZA COMPOUNDS; BLOTTING, WESTERN; CEFTRIAXONE; CELL SURVIVAL; CEPHALOSPORINS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-6; MONOCYTES; OFLOXACIN; QUINOLINES; STREPTOCOCCUS PNEUMONIAE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0344012060     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.12.3704-3707.2003     Document Type: Article

References (23)

1. Araujo, F. G., T. L. Slifer, and J. S. Remington. 2002. Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide. Clin. Microbiol. Infect. 8:26-30.
2. Brummer, E., A. Maqbool, and D. A. Stevens. 2001. Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conida. Med. Mycol. 39:509-515.
3. Forsgren, A., S. F. Scholossman, and T. F. Tedder. 1987. 4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro. Antimicrob. Agents Chemother. 31:768-773.
4. Hoffmann, A., A. Levchenko, M. L. Scott, and D. Baltimore. 2002. The decoding IκB-NF-κB signaling module: temporal control and selective gene activation. Science 298:1241-1245.
5. Ichiyama, T., M. Nishikawa, T. Yoshitomi, S. Hasegawa, T. Matsubara, T. Hayashi, and S. Furukawa. 2001. Clarithromycin inhibits NF-κB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. Antimicrob. Agents Chemother. 45:44-47.
6. Jun, Y. T., H. J. Kim, M. J. Song, J. H. Lim, D. G. Lee, K. J. Han, S. M. Choi, J. H. Yoo, W. S. Shin, and J. H. Choi. 2003. In vitro effects of ciprofloxacin and roxithromycin on apoptosis of Jurkat T lymphocytes. Antimicrob. Agents Chemother. 47:1161-1164.
7. Khan, A. A., T. R. Slifer, and J. S. Remington. 1998. Effect of trovafloxacin on production of cytokines by human monocytes. Antimicrob. Agents Chemother. 42:1713-1717.
8. Labro, M. T. 1997. The prohost effect of antimicrobial agents as a predictor of clinical outcome. J. Chemother. 9(Suppl. 1):100-108.
9. Labro, M. T. 1998. Antibacterial agents-phagocytes: new concepts for old in immunomodulation. Int. J. Antimicrob. Agents 10:11-21.
10. Labro, M. T. 2000. Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"? Clin. Microbiol. Rev. 13:615-650.
11. MacGowan, A. P. 1999. Pharmacodynamics of moxifloxacin, p. 5-15. In D. Adams and R. Finch (ed.), Moxifloxain in practice. Maxim Medical, Oxford, United Kingdom.
12. Maniatis, T. 1997. Catalysis by a multiprotein IκB kinase complex. Science 278:818-819.
13. May, M. J., and S. Ghosh. 1998. Signal transduction through NF-κB. Immunol. Today 19:80-88.
14. Morikawa, K., H. Watabe, M. Araake, and S. Morikawa. 1996. Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob. Agents Chemother. 40:1366-1370.
15. Ono, Y., Y. Ohmoto, K. Ono, Y. Sakada, and K. Murata. 2000. Effect of grepafloxacin on cytokine production in vivo. J. Antimicrob. Chemother. 46:91-94.
16. Purswani, M., S. Eckert, H. Arora, R. Johann-Liang, and G. J. Noel. 2000. The effect of three broad-spectrum antimicrobials on mononuclear cell responses to encapsulated bacteria: evidence for down-regulation of cytokine mRNA transcription by trovafloxacin. J. Antimicrob. Chemother. 46:921-929.
17. Riesbeck, K., and A. Forsgren. 1994. Limited effects of temifloxacin compared with ciprofloxacin on T-lymphocyte function. Antimicrob. Agents Chemother. 38:879-882.
18. Riesbeck, K., and A. Forsgren. 1994. Increased interleukin 2 transcription in murine lymphocytes by ciprofloxacin. Immunopharmacology 27:155-164.
19. Riesbeck, K., M. Sigvardsson, T. Leanderson, and A. Forsgren. 1994. Superinduction of cytokine gene transcription by ciprofloxacin. J. Immunol. 153:343-352.
20. Riesbeck, K., A. Forsgren, A. Henriksson, and A. Bredberg. 1998. Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes. Antimicrob. Agents Chemother. 42:1923-1930.
21. Roberts, F. A., G. J. Richardson, and S. M. Michalek. 1997. Effects of Porphyromonas gingivalis and Escherichia coli lipopolysaccharides on mononuclear phagocytes. Infect. Immun. 65:3248-3254.
22. Shalit, I., Y. Kletter, D. Halperin, D. Waldman, E. Vasserman, A. Nagler, and I. Fabian. 2001. Immunomodulatroy effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia. Eur. J. Haematol. 66:287-296.
23. Tohru, K., H. Koichi, H. Yoshihiro, G. Kazunori, K. Takao, T. Hiroshi, T. Yutaka, W. Akira, and N. Toshihiro. 2002. Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-κB transcription factors. J. Antimicrob. Chemother. 49:745-755.